Continuous treatment with lenalidomide plus low-dose dexamethasone (Ld) versus Ld induction followed by autologous stem cell transplant (ASCT) in patients with newly diagnosed multiple myeloma (NDMM): A pooled analysis of two randomized clinical trials Meeting Abstract

  

Authors:	Lentzsch, S.; Villanueva, N.; Nguyen, J.; Landau, H.; Lendvai, N.; Miao, S.; Schecter, J. M.; Reyna, M.; Mapara, M. Y.; Redner, R. L.; Chung, D. J.; Lesokhin, A. M.; Kewalramani, T.; Giralt, S.; Comenzo, R. L.; Landgren, O.; Hassoun, H.
Abstract Title:	Continuous treatment with lenalidomide plus low-dose dexamethasone (Ld) versus Ld induction followed by autologous stem cell transplant (ASCT) in patients with newly diagnosed multiple myeloma (NDMM): A pooled analysis of two randomized clinical trials
Meeting Title:	57th Annual Meeting of the American Society of Hematology (ASH)
Journal Title:	Blood
Volume:	126
Issue:	23
Meeting Dates:	2015 Dec 5-8
Meeting Location:	Orlando, FL
ISSN:	0006-4971
Publisher:	American Society of Hematology
Date Published:	2015-12-03
Language:	English
ACCESSION:	WOS:000368020100140
PROVIDER:	wos
DOI:	10.1182/blood.V126.23.1975.1975
Notes:	Meeting Abstract: 1975 -- 57th Annual Meeting of the American-Society-of-Hematology -- DEC 05-08, 2015 -- Orlando, FL -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/91554